TickerFacts.

Akari Therapeutics Plc (AKTX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$14.0K
Year ended 2024-12-31
$42.4K2014-12-31: $4.9K2015-12-31: $10.2K2016-12-31: $39.9K2017-12-31: $42.4K2018-12-31: $35.8K2019-12-31: $19.2K2020-12-31: $8.9K2021-12-31: $4.1K2022-12-31: $4.0K2023-12-31: $4.0K2024-12-31: $14.0K$14.0K
2014-12-31 Depreciation & Amortization (USD) 2024-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2024-12-31$14.0K+250.0%2026-03-30, From 2024-01-01
2023-12-31$4.0K0.0%2025-04-15, From 2023-01-01
2022-12-31$4.0Kn/c2024-03-29, From 2022-01-01
2021-12-31$4.1K-53.7%2023-05-01, From 2021-01-01
2020-12-31$8.9K-53.6%2023-05-01, From 2020-01-01
2019-12-31$19.2K-46.4%2022-05-16, From 2019-01-01
2018-12-31$35.8K-15.5%2021-04-21, From 2018-01-01
2017-12-31$42.4K+6.1%2020-03-31, From 2017-01-01
2016-12-31$39.9K+293.1%2019-04-23, From 2016-01-01
2015-12-31$10.2K+105.6%2018-07-18, From 2015-01-01
2014-12-31$4.9Kn/a2017-03-31, From 2014-01-01